Sep 2026 (Q3 FY26) — Oct 21, 2026
Healthcare Services Group Q3 FY26 — Strong Organic Growth and Strategic Acquisition
Read the full callHealthcare Services Group earnings: last reported Wed, 21 Oct 2026, for the quarter ended Sep 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 480 | +3.3% YoY | Quarterly, as filed | Quarter to Sep 2026 | Revenue from operations as filed. |
| Operating margin | Operating profit / revenue | Quarter to Sep 2026 | Not in the filed figures for the quarter to sep 2026. No older figure is substituted. | ||
| Net profit | 24.9 | −42.1% YoY | Quarterly, as filed | Quarter to Sep 2026 | Profit after tax as filed. |
Price
1Y: $18.85 on 22 Oct 2025 → $25.3. High $25.31 (17 Jul 2026), low $17.02 (17 Nov 2025).
Overview
Call summaries
Healthcare Services Group Q3 FY26 — Strong Organic Growth and Strategic Acquisition
Read the full callHCSG Q2 FY26 — Strong Operational Execution Drives Margin Outperformance and Robust Cash Flow
Read the full callEvery analysed call
Financials
Net profit, year on year: −42% (quarter to sep 2026 against sep 2025).
| Line item | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 438 | 448 | 458 | 464 | 467 | 463 | 471 | 480 |
| Profit before tax | 15 | 24 | -42 | 57 | 29 | 35 | 31 | 34 |
| Tax rate | 19.5% | 27.9% | 22.7% | 25.1% | −9.4% | 24.6% | 26.8% | 26.2% |
| Net profit | 12 | 17 | -32 | 43 | 31 | 26 | 23 | 25 |
| EPS ($ per share) | — | 0.23 | -0.44 | 0.59 | — | 0.37 | 0.33 | 0.37 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | 190 | 195 | 201 | 184 | 147 | 185 | 225 | 284 |
| Total liabilities | 252 | 262 | 315 | 335 | 303 | 334 | 303 | 284 |
| Fixed assets | 13 | 29 | — | — | — | — | — | — |
| Investments | 76 | 91 | 125 | 114 | 95 | 93 | 51 | 43 |
| Total assets | 693 | 723 | 785 | 780 | 721 | 791 | 803 | 794 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 80 | 94 | 217 | 37 | -8 | 43 | 31 | 145 |
| Cash from investing | -10 | -16 | -37 | -23 | 3 | -3 | 6 | -11 |
| Cash from financing | -54 | -76 | -68 | -83 | -39 | -12 | -31 | -63 |
| Net cash flow | 16 | 1 | 112 | -69 | -45 | 28 | 6 | 71 |
| Capital expenditure | -5 | -4 | -4 | -6 | -5 | -5 | -6 | -6 |
| Free cash flow | 75 | 89 | 213 | 31 | -13 | 38 | 24 | 139 |
94 filings between Oct 27, 2025 and Sep 30, 2026.
Purchases
None
No insider bought shares.
Sales
$3.38M
7 sales by 4 insiders
14% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Also filed: 2 dispositions to the issuer.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Orr Patrick J | — | $1.85M | Feb 18, 2026 |
| SHEA JOHN CHRISTOPHER | — | $1.11M | Feb 18, 2026 |
| Kush Andrew | — | $362.5K | Aug 4, 2026 |
| Brophy Andrew M | — | $54.2K | Feb 26, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Simmons Kurt JR Director | Award 10b5-1 plan | 734 | $15.0K |
| Sep 30, 2026 | Grant Laura K Director | Award 10b5-1 plan | 367 | $7.5K |
| Sep 30, 2026 | WHALEN THOMAS GERARD Director | Award 10b5-1 plan | 123 | $2.5K |
| Aug 4, 2026 | Kush Andrew EVP & Chief Operating Officer | Sale | 15,598 | $362.5K |
| Jul 1, 2026 | Brophy Andrew M SVP & Chief Accounting Officer | Award 10b5-1 plan | 4,381 | $0 |
| Jun 30, 2026 | Grant Laura K Director | Award 10b5-1 plan | 306 | $7.5K |
| Jun 30, 2026 | Simmons Kurt JR Director | Award 10b5-1 plan | 611 | $15.0K |
| Jun 30, 2026 | WHALEN THOMAS GERARD Director | Award 10b5-1 plan | 102 | $2.5K |
| May 27, 2026 | Singh Vikas EVP & Chief Financial Officer | Option exercise | 2,202 | $0 |
| May 27, 2026 | Singh Vikas EVP & Chief Financial Officer | Tax withheld | 935 | $0 |
| May 26, 2026 | Gallagher Thomas Michael Director | Award | 1,969 | $40.0K |
| May 26, 2026 | WHALEN THOMAS GERARD Director | Award 10b5-1 plan | 1,969 | $40.0K |
| May 26, 2026 | Grant Laura K Director | Award | 1,969 | $40.0K |
| May 26, 2026 | Simmons Kurt JR Director | Award | 1,969 | $40.0K |
| May 26, 2026 | Visconto Jude Director | Award | 1,969 | $40.0K |
| May 26, 2026 | Castagnino Daniela Director | Award | 1,969 | $40.0K |
| May 26, 2026 | Casey Diane S Director | Award | 1,969 | $40.0K |
| May 26, 2026 | Ottaviano Dino D Director | Award | 1,969 | $40.0K |
| Mar 31, 2026 | Grant Laura K Director | Award 10b5-1 plan | 405 | $7.5K |
| Mar 31, 2026 | WHALEN THOMAS GERARD Director | Award 10b5-1 plan | 135 | $2.5K |
| Mar 31, 2026 | Simmons Kurt JR Director | Award 10b5-1 plan | 809 | $15.0K |
| Feb 26, 2026 | Brophy Andrew M SVP & Chief Accounting Officer | Sale 10b5-1 plan | 2,490 | $54.2K |
| Feb 24, 2026 | Bundick Jason J EVP/Gen. Counsel/Corp. Secty. | Tax withheld 10b5-1 plan | 4,091 | $87.5K |
| Feb 24, 2026 | Bundick Jason J EVP/Gen. Counsel/Corp. Secty. | Option exercise 10b5-1 plan | 9,643 | $0 |
| Feb 24, 2026 | WAHL Theodore President & CEO | Tax withheld 10b5-1 plan | 26,959 | $576.9K |
| Feb 24, 2026 | WAHL Theodore President & CEO | Option exercise 10b5-1 plan | 63,551 | $0 |
| Feb 24, 2026 | WAHL Theodore President & CEO | Tax withheld 10b5-1 plan | 9,434 | $201.9K |
| Feb 24, 2026 | SHEA JOHN CHRISTOPHER EVP & Chief Admin. Officer | Option exercise 10b5-1 plan | 4,416 | $0 |
| Feb 24, 2026 | WAHL Theodore President & CEO | Option exercise 10b5-1 plan | 22,238 | $0 |
| Feb 24, 2026 | Kush Andrew EVP & Chief Operating Officer | Option exercise 10b5-1 plan | 4,416 | $0 |
| Feb 24, 2026 | Bundick Jason J EVP/Gen. Counsel/Corp. Secty. | Tax withheld 10b5-1 plan | 1,432 | $30.6K |
| Feb 24, 2026 | Bundick Jason J EVP/Gen. Counsel/Corp. Secty. | Option exercise 10b5-1 plan | 3,374 | $0 |
| Feb 24, 2026 | SHEA JOHN CHRISTOPHER EVP & Chief Admin. Officer | Tax withheld 10b5-1 plan | 5,353 | $114.6K |
| Feb 24, 2026 | SHEA JOHN CHRISTOPHER EVP & Chief Admin. Officer | Option exercise 10b5-1 plan | 12,618 | $0 |
| Feb 24, 2026 | SHEA JOHN CHRISTOPHER EVP & Chief Admin. Officer | Tax withheld 10b5-1 plan | 1,874 | $40.1K |
| Feb 24, 2026 | Brophy Andrew M SVP & Chief Accounting Officer | Tax withheld 10b5-1 plan | 239 | $5.1K |
| Feb 24, 2026 | Orr Patrick J EVP & Chief Revenue Officer | Tax withheld 10b5-1 plan | 4,049 | $86.6K |
| Feb 24, 2026 | Orr Patrick J EVP & Chief Revenue Officer | Option exercise 10b5-1 plan | 9,543 | $0 |
| Feb 24, 2026 | Orr Patrick J EVP & Chief Revenue Officer | Tax withheld 10b5-1 plan | 1,417 | $30.3K |
| Feb 24, 2026 | Orr Patrick J EVP & Chief Revenue Officer | Option exercise 10b5-1 plan | 3,340 | $0 |
| Feb 24, 2026 | Kush Andrew EVP & Chief Operating Officer | Tax withheld 10b5-1 plan | 5,353 | $114.6K |
| Feb 24, 2026 | Kush Andrew EVP & Chief Operating Officer | Option exercise 10b5-1 plan | 12,618 | $0 |
| Feb 24, 2026 | Kush Andrew EVP & Chief Operating Officer | Tax withheld 10b5-1 plan | 1,874 | $40.1K |
| Feb 18, 2026 | Orr Patrick J EVP & Chief Revenue Officer | Sale | 11,167 | $229.5K |
| Feb 18, 2026 | Orr Patrick J EVP & Chief Revenue Officer | Sale | 33,448 | $686.4K |
| Feb 18, 2026 | Orr Patrick J EVP & Chief Revenue Officer | Option exercise | 7,016 | $96.3K |
| Feb 18, 2026 | Orr Patrick J EVP & Chief Revenue Officer | Option exercise | 21,075 | $381.5K |
| Feb 18, 2026 | SHEA JOHN CHRISTOPHER EVP & Chief Admin. Officer | Sale | 38,857 | $791.1K |
| Feb 18, 2026 | SHEA JOHN CHRISTOPHER EVP & Chief Admin. Officer | Option exercise | 9,278 | $127.3K |
| Feb 18, 2026 | SHEA JOHN CHRISTOPHER EVP & Chief Admin. Officer | Option exercise | 29,579 | $535.4K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow HEALTHCARE SERVICES GROUP INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading